327 related articles for article (PubMed ID: 10441575)
1. EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas.
Bovée JV; Cleton-Jansen AM; Wuyts W; Caethoven G; Taminiau AH; Bakker E; Van Hul W; Cornelisse CJ; Hogendoorn PC
Am J Hum Genet; 1999 Sep; 65(3):689-98. PubMed ID: 10441575
[TBL] [Abstract][Full Text] [Related]
2. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.
de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV
Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604
[TBL] [Abstract][Full Text] [Related]
3. Ext-mutation analysis in Italian sporadic and hereditary osteochondromas.
Gigante M; Matera MG; Seripa D; Izzo AM; Venanzi R; Giannotti A; Digilio MC; Gravina C; Lazzari M; Monteleone G; Monteleone M; Dallapiccola B; Fazio VM
Int J Cancer; 2001 Nov; 95(6):378-83. PubMed ID: 11668521
[TBL] [Abstract][Full Text] [Related]
4. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760
[TBL] [Abstract][Full Text] [Related]
5. Somatic loss of an EXT2 gene mutation during malignant progression in a patient with hereditary multiple osteochondromas.
Musso N; Caronia FP; Castorina S; Lo Monte AI; Barresi V; Condorelli DF
Cancer Genet; 2015 Mar; 208(3):62-7. PubMed ID: 25744876
[TBL] [Abstract][Full Text] [Related]
6. Methylation status of EXT1 and EXT2 promoters and two mutations of EXT2 in chondrosarcoma.
Tsuchiya T; Osanai T; Ogose A; Tamura G; Chano T; Kaneko Y; Ishikawa A; Orui H; Wada T; Ikeda T; Namba M; Takigawa M; Kawashima H; Hotta T; Tsuchiya A; Ogino T; Motoyama T
Cancer Genet Cytogenet; 2005 Apr; 158(2):148-55. PubMed ID: 15796962
[TBL] [Abstract][Full Text] [Related]
7. No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas.
Reijnders CM; Waaijer CJ; Hamilton A; Buddingh EP; Dijkstra SP; Ham J; Bakker E; Szuhai K; Karperien M; Hogendoorn PC; Stringer SE; Bovée JV
Am J Pathol; 2010 Oct; 177(4):1946-57. PubMed ID: 20813973
[TBL] [Abstract][Full Text] [Related]
8. Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12 (EXT2) in patients with sporadic and hereditary osteochondromas.
Bridge JA; Nelson M; Orndal C; Bhatia P; Neff JR
Cancer; 1998 May; 82(9):1657-63. PubMed ID: 9576285
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma.
Bovée JV; van den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
Lab Invest; 2000 Dec; 80(12):1925-34. PubMed ID: 11140704
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of hereditary multiple exostoses in the Chinese.
Xu L; Xia J; Jiang H; Zhou J; Li H; Wang D; Pan Q; Long Z; Fan C; Deng HX
Hum Genet; 1999; 105(1-2):45-50. PubMed ID: 10480354
[TBL] [Abstract][Full Text] [Related]
11. Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation.
Zuntini M; Pedrini E; Parra A; Sgariglia F; Gentile FV; Pandolfi M; Alberghini M; Sangiorgi L
Oncogene; 2010 Jul; 29(26):3827-34. PubMed ID: 20418910
[TBL] [Abstract][Full Text] [Related]
12. A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses.
Matsumoto K; Irie F; Mackem S; Yamaguchi Y
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10932-7. PubMed ID: 20534475
[TBL] [Abstract][Full Text] [Related]
13. [From gene to disease; hereditary multiple exostoses].
Wuyts W; Bovée JV; Hogendoorn PC
Ned Tijdschr Geneeskd; 2002 Jan; 146(4):162-4. PubMed ID: 11845565
[TBL] [Abstract][Full Text] [Related]
14. Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies.
Hecht JT; Hogue D; Wang Y; Blanton SH; Wagner M; Strong LC; Raskind W; Hansen MF; Wells D
Am J Hum Genet; 1997 Jan; 60(1):80-6. PubMed ID: 8981950
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic and molecular cytogenetic evidence of recurrent 8q24.1 loss in osteochondroma.
Feely MG; Boehm AK; Bridge RS; Krallman PA; Neff JR; Nelson M; Bridge JA
Cancer Genet Cytogenet; 2002 Sep; 137(2):102-7. PubMed ID: 12393280
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses.
Wuyts W; Van Hul W; De Boulle K; Hendrickx J; Bakker E; Vanhoenacker F; Mollica F; Lüdecke HJ; Sayli BS; Pazzaglia UE; Mortier G; Hamel B; Conrad EU; Matsushita M; Raskind WH; Willems PJ
Am J Hum Genet; 1998 Feb; 62(2):346-54. PubMed ID: 9463333
[TBL] [Abstract][Full Text] [Related]
17. The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions.
Hameetman L; Szuhai K; Yavas A; Knijnenburg J; van Duin M; van Dekken H; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
J Natl Cancer Inst; 2007 Mar; 99(5):396-406. PubMed ID: 17341731
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma.
Bovée JV; Cleton-Jansen AM; Kuipers-Dijkshoorn NJ; van den Broek LJ; Taminiau AH; Cornelisse CJ; Hogendoorn PC
Genes Chromosomes Cancer; 1999 Nov; 26(3):237-46. PubMed ID: 10502322
[TBL] [Abstract][Full Text] [Related]
19. Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses.
Park KJ; Shin KH; Ku JL; Cho TJ; Lee SH; Choi IH; Phillipe C; Monaco AP; Porter DE; Park JG
J Hum Genet; 1999; 44(4):230-4. PubMed ID: 10429361
[TBL] [Abstract][Full Text] [Related]
20. Similar cytogenetic findings in two synchronous secondary peripheral chondrosarcomas in a patient with multiple osteochondromas.
Kyriazoglou AI; Dimitriadis E; Arnogiannaki N; Brandal P; Heim S; Pandis N
Cancer Genet; 2011 Dec; 204(12):677-81. PubMed ID: 22285020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
